This document, **Registration Provision Procedure (YGD 0405, Revision 3)**, outlines the YTY GROUP’s standardized procedures for registering medical devices in key international markets to ensure regulatory compliance. ### **Key Summary Points:** * **Objective and Scope:** To facilitate medical device registration and ensure compliance with regulatory requirements in the United States, Australia, Brazil, Canada, and Japan. * **Responsibilities:** Defines roles for the Head of Regulatory Affairs (managing submissions and feedback) and Department Heads (maintaining records and manufacturing standards). * **Regional Registration Procedures:** Detailed steps are provided for specific regulatory bodies: * **USA (FDA):** Focuses on establishment registration, device listing via the FURLS system, and the 510(k) premarket notification process. * **Canada (Health Canada):** Emphasizes ISO 13485:2016 compliance and the requirements for obtaining Medical Device Establishment Licenses (MDEL) or Medical Device Licenses (MDL). * **Australia (TGA):** Covers conformity assessments, appointing a local sponsor, inclusion in the Australian Register of Therapeutic Goods (ARTG), and the use of GMDN codes. * **Brazil (ANVISA):** Outlines the need for a Brazilian Registration Holder (BRH), Good Manufacturing Practice (BGMP) certification, and specific technical documentation. * **Japan (MHLW/PMDA):** Details requirements for Foreign Manufacturer Registration (FMR), appointing a Marketing Authorization Holder (MAH), and compliance with MHLW Ordinance No. 169. * **Post-Registration Maintenance:** Section 6.6 establishes strict protocols for notifying respective regulatory authorities regarding significant changes to registered devices, such as modifications in design, materials, manufacturing sites, or sterilization methods. * **Records:** Refers to supplementary registration flow charts and a country compliance matrix (YGD 0405/01 and 02).